World leaders have endorsed a major shift in global health policy: mental health should be managed in the same settings as physical illness, including primary care clinics. The United Nations is preparing to finalize a declaration placing mental health on equal footing with chronic diseases such as cancer and cardiovascular illness, the World
Health Organization confirmed.
The document aims to bring timely treatment to everyday healthcare environments rather than relying on specialized psychiatric systems that leave many patients unserved. Its target is substantial: reaching an estimated 150 million more people with treatment by 2030.
Treatment gaps widely acknowledged
Despite broad political support, health professionals say real-world access remains the decisive challenge. More than one billion people worldwide live with mental health conditions, yet fewer than 7 percent are estimated to receive evidence-based treatment. In many regions, patients face prolonged delays before clinical support becomes available.
Dr Hannah Nearney, a UK clinician specializing in depression treatment, stresses that untreated mental health symptoms can set off damaging cycles for physical illness.
“Mental health influences sleep, immunity, medication adherence, and stress responses,” she said. “It directly affects the progression of chronic disease. Treating one without the other leaves both vulnerable.”
A recent European study of 275,000 adults found individuals with depressive symptoms had significantly higher rates of chronic disease, while those already living with chronic illnesses were more likely to experience depression. Clinicians say this two-way link underscores the urgency of integrating care.
Primary care still lacks tools
Doctors working in community clinics often serve as the first point of contact for patients, yet they report limited treatment options and short consultation times.
“When a patient walks into a GP’s office, their mental health should receive the same attention as vital signs,” said Dr Kultar Singh Garcha, another U.K. physician. “But the current system rarely allows that level of response.”
In many countries, the default response to long waitlists is a prescription—sometimes added to an already long list of medications. Experts say treatment expansion will require scalable options that do not increase pharmaceutical burden or side-effect risks.
Non-drug treatments gaining clinical backing
Among emerging approaches, non-pharmacological treatments such as brain stimulation therapy are beginning to appear in some primary care pathways. These options can be prescribed and monitored remotely, allowing care to extend beyond clinic walls.
Pilot programs in the United Kingdom have reported symptom reductions among participating patients, but clinicians note that availability remains limited geographically, and awareness among healthcare providers varies.
“Our systems often struggle to adopt new treatments, even when they are supported by evidence,” Dr Garcha said. “Without integration into primary care, these remain niche rather than standard care.”
Policies move ahead, systems must follow
Experts say wider regulatory alignment and reimbursement will be necessary for most countries to scale non-drug interventions and bridge longstanding care gaps. They view the UN declaration as a significant political shift but caution that implementation will test governments and health systems.
Dr Nearney summarized the challenge ahead: “The recognition is finally there. The question now is how quickly access can match the need.”
